
                <!DOCTYPE html>
                <html lang="en">
                <head>
                    <meta charset="UTF-8">
                    <meta name="viewport" content="width=device-width, initial-scale=1.0">
                    <title>Highlights from AAO 2024</title>
                </head>
                <body>
                    <h1>Highlights from AAO 2024</h1>
                    <h2>Headings:</h2>
                    <h1>Highlights from AAO 2024</h1>
                    <h2>Paragraphs:</h2>
                    <p>In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Ophthalmology 2024 Meeting with a focus on AMD and retina.</p><p>David A. Eichenbaum, MD,discusses results from a phase 1 trial investigating axitinib for the treatment of neovascular age-related macular degeneration.:28</p><p>Douglas Lovediscusses the companyâ€™s phase 3 program in geographic atrophy.2:37</p><p>Pravin U. Dugel, MD,discusses the next steps for the phase 3 SOL-1 and SOL-R studies.3:54</p><p>Jeremiah Brown, MS, MD,presents results from the phase 4 Elevatum trial investigating faricimab for diabetic macular edema.5:17</p><p>Read the full coverage here:</p><p>https://www.healio.com/news/ophthalmology/20241024/video-axitinib-shows-clinically-meaningful-treatment-burden-reduction-in-wet-amd</p><p>https://www.healio.com/news/ophthalmology/20241023/video-phase-3-geographic-atrophy-program-focuses-on-visual-acuity</p><p>https://www.healio.com/news/ophthalmology/20241021/video-ocular-therapeutix-shares-update-on-phase-3-axpaxli-studies</p><p>https://www.healio.com/news/ophthalmology/20241018/video-faricimab-shows-amazing-outcomes-in-underrepresented-patients-with-dme</p><p>Teleretinal screening for diabetic retinopathy beneficial</p><p>Source: Weng CY. The use of teleretinal screening for diabetic retinopathy. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.</p><p>Oral treatment aims to reduce GA progression by slowing vitamin A dimerization</p><p>Source: Melamud A. Gildeuretinol in geographic atrophy: Results from SAGA, a 2-year, randomized, double-masked, placebo-controlled Study. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.</p><p>Fas inhibitor shows benefit in some cases of macula-off rhegmatogenous retinal detachment</p><p>Source: Borkar DS. Fas inhibition with intravitreal ONL1204 for the treatment of macula-off rhegmatogenous retinal detachment: Results from a phase 2 study. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.</p><p>Collapse</p><p>Read more about</p><p>Play on Healio</p><p>Follow Healio</p><p>About</p><p>Account Information</p><p>Contact Us</p><p>Legal</p><p>Sign Up for Email</p><p>Get the latest news and education delivered to your inbox</p><p>The email address associated with your Healio account is:</p><p></p><p>If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link.</p><p>Would you like to receive email reminders to complete your saved activities from Healio CME?</p><p>Activity saved! You'll receive reminders to complete your saved activities from Healio CME.</p>
                </body>
                </html>
            